Cargando…

A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia

BACKGROUND: A number of studies have revealed that Francisella tularensis (FT) suppresses innate immune responses such as chemokine/cytokine production and neutrophil recruitment in the lungs following pulmonary infection via an unidentified mechanism. The ability of FT to evade early innate immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayakar, Himangi R, Parvathareddy, Jyothi, Fitzpatrick, Elizabeth A, Bina, Xiaowen R, Bina, James E, Re, Fabio, Emery, Felicia D, Miller, Mark A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173336/
https://www.ncbi.nlm.nih.gov/pubmed/21819572
http://dx.doi.org/10.1186/1471-2180-11-179
_version_ 1782211944388755456
author Jayakar, Himangi R
Parvathareddy, Jyothi
Fitzpatrick, Elizabeth A
Bina, Xiaowen R
Bina, James E
Re, Fabio
Emery, Felicia D
Miller, Mark A
author_facet Jayakar, Himangi R
Parvathareddy, Jyothi
Fitzpatrick, Elizabeth A
Bina, Xiaowen R
Bina, James E
Re, Fabio
Emery, Felicia D
Miller, Mark A
author_sort Jayakar, Himangi R
collection PubMed
description BACKGROUND: A number of studies have revealed that Francisella tularensis (FT) suppresses innate immune responses such as chemokine/cytokine production and neutrophil recruitment in the lungs following pulmonary infection via an unidentified mechanism. The ability of FT to evade early innate immune responses could be a very important virulence mechanism for this highly infectious bacterial pathogen. RESULTS: Here we describe the characterization of a galU mutant strain of FT live vaccine strain (LVS). We show that the galU mutant was highly attenuated in a murine model of tularemia and elicited more robust innate immune responses than the wild-type (WT) strain. These studies document that the kinetics of chemokine expression and neutrophil recruitment into the lungs of mice challenged with the galU mutant strain are significantly more rapid than observed with WT FT, despite the fact that there were no observed differences in TLR2 or TLR4 signaling or replication/dissemination kinetics during the early stages of infection. We also show that the galU mutant had a hypercytotoxic phenotype and more rapidly induced the production of IL-1β following infection either in vitro or in vivo, indicating that attenuation of the galU mutant strain may be due (in part) to more rapid activation of the inflammasome and/or earlier death of FT infected cells. Furthermore, we show that infection of mice with the galU mutant strain elicits protective immunity to subsequent challenge with WT FT. CONCLUSIONS: Disruption of the galU gene of FTLVS has little (if any) effect on in vivo infectivity, replication, or dissemination characteristics, but is highly attenuating for virulence. The attenuated phenotype of this mutant strain of FT appears to be related to its increased ability to induce innate inflammatory responsiveness, resulting in more rapid recruitment of neutrophils to the lungs following pneumonic infection, and/or to its ability to kill infected cells in an accelerated fashion. These results have identified two potentially important virulence mechanisms used by FT. These findings could also have implications for design of a live attenuated vaccine strain of FT because sublethal infection of mice with the galU mutant strain of FTLVS promoted development of protective immunity to WT FTLVS.
format Online
Article
Text
id pubmed-3173336
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31733362011-09-15 A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia Jayakar, Himangi R Parvathareddy, Jyothi Fitzpatrick, Elizabeth A Bina, Xiaowen R Bina, James E Re, Fabio Emery, Felicia D Miller, Mark A BMC Microbiol Research Article BACKGROUND: A number of studies have revealed that Francisella tularensis (FT) suppresses innate immune responses such as chemokine/cytokine production and neutrophil recruitment in the lungs following pulmonary infection via an unidentified mechanism. The ability of FT to evade early innate immune responses could be a very important virulence mechanism for this highly infectious bacterial pathogen. RESULTS: Here we describe the characterization of a galU mutant strain of FT live vaccine strain (LVS). We show that the galU mutant was highly attenuated in a murine model of tularemia and elicited more robust innate immune responses than the wild-type (WT) strain. These studies document that the kinetics of chemokine expression and neutrophil recruitment into the lungs of mice challenged with the galU mutant strain are significantly more rapid than observed with WT FT, despite the fact that there were no observed differences in TLR2 or TLR4 signaling or replication/dissemination kinetics during the early stages of infection. We also show that the galU mutant had a hypercytotoxic phenotype and more rapidly induced the production of IL-1β following infection either in vitro or in vivo, indicating that attenuation of the galU mutant strain may be due (in part) to more rapid activation of the inflammasome and/or earlier death of FT infected cells. Furthermore, we show that infection of mice with the galU mutant strain elicits protective immunity to subsequent challenge with WT FT. CONCLUSIONS: Disruption of the galU gene of FTLVS has little (if any) effect on in vivo infectivity, replication, or dissemination characteristics, but is highly attenuating for virulence. The attenuated phenotype of this mutant strain of FT appears to be related to its increased ability to induce innate inflammatory responsiveness, resulting in more rapid recruitment of neutrophils to the lungs following pneumonic infection, and/or to its ability to kill infected cells in an accelerated fashion. These results have identified two potentially important virulence mechanisms used by FT. These findings could also have implications for design of a live attenuated vaccine strain of FT because sublethal infection of mice with the galU mutant strain of FTLVS promoted development of protective immunity to WT FTLVS. BioMed Central 2011-08-05 /pmc/articles/PMC3173336/ /pubmed/21819572 http://dx.doi.org/10.1186/1471-2180-11-179 Text en Copyright ©2011 Jayakar et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jayakar, Himangi R
Parvathareddy, Jyothi
Fitzpatrick, Elizabeth A
Bina, Xiaowen R
Bina, James E
Re, Fabio
Emery, Felicia D
Miller, Mark A
A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia
title A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia
title_full A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia
title_fullStr A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia
title_full_unstemmed A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia
title_short A galU mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia
title_sort galu mutant of francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173336/
https://www.ncbi.nlm.nih.gov/pubmed/21819572
http://dx.doi.org/10.1186/1471-2180-11-179
work_keys_str_mv AT jayakarhimangir agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT parvathareddyjyothi agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT fitzpatrickelizabetha agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT binaxiaowenr agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT binajamese agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT refabio agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT emeryfeliciad agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT millermarka agalumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT jayakarhimangir galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT parvathareddyjyothi galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT fitzpatrickelizabetha galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT binaxiaowenr galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT binajamese galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT refabio galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT emeryfeliciad galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia
AT millermarka galumutantoffrancisellatularensisisattenuatedforvirulenceinamurinepulmonarymodeloftularemia